Verma S, McGuire DK, Bain SC, Bhatt DL, Leiter LA, Mazer CD et al (2020) Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
Who should not take PT-141
7 A case report describes the outcomes of two separate pregnancies in a 40-year-old woman with diabetes and obesity undergoing exenatide treatment
Currently, no clinical trials targeting cuproptosis have been reported in OSCC
This reactivation can occur as a result of local injury or systemic factors such as stress (emotional and environmental), fever, trauma, or menstrual periods
Increased ventricles and sulcal dilatation are a consequence of neuron degeneration within the brain